keyword
https://read.qxmd.com/read/38652865/effect-of-tyrosine-kinase-inhibitors-on-male-fertility-in-patients-with-chronic-phase-chronic-myeloid-leukemia
#1
JOURNAL ARTICLE
George Nesr, Simone Claudiani, Dragana Milojkovic, Andrew Innes, Fiona Fernando, Irene Caballes, Patience Mungozi, Richard Szydlo, Silvia Lovato, Channa Jayasena, Jane Apperley
Advancements in the management of patients with chronic myeloid leukemia (CML) allowed them to achieve survival comparable with their healthy counterparts. Consequently, their care has widened with growing focus on quality of life, including parenting children. Although tyrosine kinase inhibitors (TKI) are contraindicated in pregnancy given their teratogenic effect, their effect on male fertility is less clear with contradictory results from animal studies and case reports/series. We compared the sperm analysis parameters, as the gold-standard assessment for male fertility, of 11 patients with CP- CML before and after TKI therapy...
April 23, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38650773/cingulotomy-for-intractable-pain-a-systematic-review-of-an-underutilized-procedure
#2
REVIEW
Billy McBenedict, Wilhelmina N Hauwanga, Mariana P Pires, José Geraldo M Netto, Dulci Petrus, Jumana A Kanchwala, Rhea Joshi, Shaista Rizwan Ahamed Alurkar, Otari Chankseliani, Zaeemah Mansoor, Sona Subash, Berley Alphonse, Ana Abrahão, Bruno Lima Pessôa
Pain management is a critical aspect of cancer treatment and palliative care, where pain can significantly impact quality of life. Chronic pain, which affects a significant number of people worldwide, remains a prevalent and challenging symptom for patients. While medications and psychosocial support systems play a role in pain management, surgical and radiological interventions, including cingulotomy, may be necessary for refractory cases. Cingulotomy, a neurosurgical procedure targeting the cingulate gyrus, aims to disrupt neural pathways associated with emotional processing and pain sensation, thereby reducing the affective component of pain...
March 2024: Curēus
https://read.qxmd.com/read/38648790/2-hydroxyglutarate-as-an-mr-spectroscopic-predictor-of-an-idh-mutation-in-gliomas
#3
JOURNAL ARTICLE
Jochen Bauer, Heiner N Raum, Harald Kugel, Michael Müther, Manoj Mannil, Walter Heindel
The mutated enzyme isocitrate dehydrogenase (IDH) 1 and 2 has been detected in various tumor entities such as gliomas and can convert α-ketoglutarate into the oncometabolite 2-hydroxyglutarate (2-HG). This neuro-oncologically significant metabolic product can be detected by MR spectroscopy and is therefore suitable for noninvasive glioma classification and therapy monitoring.This paper provides an up-to-date overview of the methodology and relevance of 1 H-MR spectroscopy (MRS) in the oncological primary and follow-up diagnosis of gliomas...
April 22, 2024: RöFo: Fortschritte Auf Dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
https://read.qxmd.com/read/38644578/c-ebp%C3%AE-a-transcription-factor-associated-with-the-irreversible-progression-of-alzheimer-s-disease
#4
REVIEW
Qing Yao, Chubing Long, Pengcheng Yi, Guangyong Zhang, Wei Wan, Xiuqin Rao, Jun Ying, Weidong Liang, Fuzhou Hua
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder distinguished by a swift cognitive deterioration accompanied by distinctive pathological hallmarks such as extracellular Aβ (β-amyloid) peptides, neuronal neurofibrillary tangles (NFTs), sustained neuroinflammation, and synaptic degeneration. The elevated frequency of AD cases and its proclivity to manifest at a younger age present a pressing challenge in the quest for novel therapeutic interventions. Numerous investigations have substantiated the involvement of C/EBPβ in the progression of AD pathology, thus indicating its potential as a therapeutic target for AD treatment...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38636451/14-3-3%C3%AE-a-novel-player-in-tdp-43-pathophysiology-implications-for-als-ftd
#5
JOURNAL ARTICLE
Bilal Khalil, Sandrine Da Cruz
In this issue of Neuron, Ke et al.1 report a novel non-canonical interaction between 14-3-3θ and TDP-43 that impacts loss-of-function and gain-of-toxic pathology in TDP-43 proteinopathies. The authors further provide proof of principle for a 14-3-3θ-targeted gene therapy to reduce TDP-43-induced deficits in transgenic TDP-43 mutant mice.
April 17, 2024: Neuron
https://read.qxmd.com/read/38633517/an-international-survey-of-extracorporeal-membrane-oxygenation-education-and-credentialing-practices
#6
JOURNAL ARTICLE
Bhoumesh Patel, Ahmed S Said, Angelo Justus, Darryl Abrams, Tái Pham, Marta Velia Antonini, Elizabeth Moore, Kiran Shekar, Bishoy Zakhary
BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) has grown rapidly over the past decades because of evolving indications, advances in circuit technology, and encouraging results from modern trials. Because ECMO is a complex and highly invasive therapy that requires a multidisciplinary team, optimal education, training, and credentialing remain a challenge. OBJECTIVE: The primary objectives of this study were to investigate the prevalence and application of ECMO education and ECMO practitioner credentialing at ECMO centers globally...
March 2024: ATS scholar
https://read.qxmd.com/read/38633477/21st-century-critical-care-medicine-an-overview
#7
REVIEW
Smitesh Padte, Vikramaditya Samala Venkata, Priyal Mehta, Sawsan Tawfeeq, Rahul Kashyap, Salim Surani
Critical care medicine in the 21st century has witnessed remarkable advancements that have significantly improved patient outcomes in intensive care units (ICUs). This abstract provides a concise summary of the latest developments in critical care, highlighting key areas of innovation. Recent advancements in critical care include Precision Medicine: Tailoring treatments based on individual patient characteristics, genomics, and biomarkers to enhance the effectiveness of therapies. The objective is to describe the recent advancements in Critical Care Medicine...
March 9, 2024: World Journal of Critical Care Medicine
https://read.qxmd.com/read/38632155/treatment-of-myelodysplastic-syndromes-for-older-patients-current-state-of-science-challenges-and-opportunities
#8
REVIEW
Tariq Kewan, Maximillian Stahl, Jan Philipp Bewersdorf, Amer M Zeidan
PURPOSE OF REVIEW: Myelodysplastic syndromes/neoplasms (MDS) represent a diverse group of pathologically distinct diseases with varying prognoses and risks of leukemia progression. This review aims to discuss current treatment options for elderly patients with MDS, focusing on patients ineligible for intensive chemotherapy or allogenic hematopoietic stem cell transplantation (HSCT). The challenges associated with treatment in this population and emerging therapeutic prospects are also explored...
April 18, 2024: Current Hematologic Malignancy Reports
https://read.qxmd.com/read/38631683/regimen-for-accelerated-propranolol-initial-dosing-rapid
#9
JOURNAL ARTICLE
Charles Y Huang, Marissa J Perman, Albert C Yan
BACKGROUND: Infantile hemangiomas are common vascular tumors in children. Propranolol has proven effective in treating infantile hemangiomas and while generally safe, has potential risk for more serious side effects of hypoglycemia, hypotension, bradycardia, bronchospasm, and cardiovascular or respiratory compromise. Current prescribing guidelines recommend initiating propranolol doses at 1 mg/kg/day, with up-titration to 2 mg/kg/day. This study aims to compare the incidence of adverse events in infants and children treated with propranolol initiated at 1 mg/kg/day versus being initiated directly at 2 mg/kg/day...
April 17, 2024: Pediatric Dermatology
https://read.qxmd.com/read/38631307/validierung-eines-fragebogeninstrumentes-zur-erfassung-des-erlebens-von-natur-die-experience-of-nature-scale
#10
JOURNAL ARTICLE
Arndt Büssing, Daniela Rodrigues Recchia, Miriam Ortiz
Hintergrund: In den letzten Jahren ist insbesondere die Natur als Ressource in das Interesse der gesundheitspsychologischen Forschung gerückt. In Ergänzung zum etablierten Konzept der Naturzuwendung als Haltung wurde ein Forschungsinstrument zum Naturerleben entwickelt, welches das subjektive, teilweise intentionale Erleben von Natur unter unterschiedlichen Aspekten beleuchtet. Dazu gehören insbesondere Natur als Erlebensraum, um sich von der Alltagsbelastung distanzieren zu können, um Auszeit durch Ruhe und Stille finden zu können, um emotionale Ausgeglichenheit zu erlangen, Natur als Ort der Faszination und des Staunens, Naturerleben als Basis für einen verantwortlichen Umgang mit der Natur...
April 17, 2024: Complementary Medicine Research
https://read.qxmd.com/read/38630422/capsules-for-the-diagnosis-and-treatment-of-gastrointestinal-motility-disorders-a-game-changer
#11
REVIEW
Irene Sonu, Sun Jung Oh, Satish S C Rao
PURPOSE OF REVIEW: Over the last few decades, there have been remarkable strides in endoscopy and radiological imaging that have advanced gastroenterology. However, the management of neurogastroenterological disorders has lagged behind, in part handicapped by the use of catheter-based manometry that is both non-physiological and uncomfortable. The advent of capsule technology has been a game changer for both diagnostic and therapeutic applications. RECENT FINDINGS: Here, we discuss several capsule devices that are available or under investigation...
April 17, 2024: Current Gastroenterology Reports
https://read.qxmd.com/read/38629006/pragmatic-neurorehabilitation-approach-for-improving-quality-of-life-in-duchenne-muscular-dystrophy-a-case-report
#12
Radha Nangliya, Anam R Sasun, Snehal Samal
This case report provides insights into the physiotherapy management of a 12-year-old male with Duchenne muscular dystrophy (DMD). DMD is a devastating genetic disorder characterized by progressive muscle degeneration and weakness. Skeletal muscle degeneration is induced by a genetic disorder. It is a common X-linked condition that causes hypertrophy of the calves and proximal muscular weakness in children. It frequently results in early mortality, wheelchair confinement, and delays in motor development...
March 2024: Curēus
https://read.qxmd.com/read/38625649/chinese-translation-and-validation-of-the-center-for-neurologic-study-lability-scale
#13
JOURNAL ARTICLE
Lu Chen, Shan Ye, Davan Murphy, Jieying Wu, Hui Zhang, Hong Liu, Boliang Zou, Guanghao Hou, Nan Zhang, Tielun Yin, Richard A Smith, Dongsheng Fan
INTRODUCTION: Pseudobulbar palsy is a common symptom in patients with amyotrophic lateral sclerosis (ALS), but it is often underdiagnosed or misdiagnosed as other diseases. The Center for Neurologic Study Lability Scale (CNS-LS) is a self-report scale consisting of seven questions designed for evaluating pseudobulbar affect (PBA). The current study aimed to validate a Chinese version of the CNS-LS. METHODS: The Chinese version of the CNS-LS was obtained through a standardized forward-backward translation and cultural adaptation...
April 16, 2024: Neurology and Therapy
https://read.qxmd.com/read/38623905/from-intestinal-failure-to-transplantation-review-on-the-current-need-for-transplant-indications-under-multidisciplinary-transplant-programs-worldwide
#14
REVIEW
Vikram K Raghu, Carolina Rumbo, Simon P Horslen
INTRODUCTION: Intestinal failure, defined as the loss of gastrointestinal function to the point where nutrition cannot be maintained by enteral intake alone, presents numerous challenges in children, not least the timing of consideration of intestine transplantation. OBJECTIVES: To describe the evolution of care of infants and children with intestinal failure including parenteral nutrition, intestine transplantation, and contemporary intestinal failure care. METHODS: The review is based on the authors' experience supported by an in-depth review of the published literature...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38621131/reversal-of-c9orf72-mutation-induced-transcriptional-dysregulation-and-pathology-in-cultured-human-neurons-by-allele-specific-excision
#15
JOURNAL ARTICLE
Aradhana Sachdev, Kamaljot Gill, Maria Sckaff, Alisha M Birk, Olubankole Aladesuyi Arogundade, Katherine A Brown, Runvir S Chouhan, Patrick Oliver Issagholian-Lewin, Esha Patel, Hannah L Watry, Mylinh T Bernardi, Kathleen C Keough, Yu-Chih Tsai, Alec Simon Tulloch Smith, Bruce R Conklin, Claire Dudley Clelland
Efforts to genetically reverse C9orf72 pathology have been hampered by our incomplete understanding of the regulation of this complex locus. We generated five different genomic excisions at the C9orf72 locus in a patient-derived induced pluripotent stem cell (iPSC) line and a non-diseased wild-type (WT) line (11 total isogenic lines), and examined gene expression and pathological hallmarks of C9 frontotemporal dementia/amyotrophic lateral sclerosis in motor neurons differentiated from these lines. Comparing the excisions in these isogenic series removed the confounding effects of different genomic backgrounds and allowed us to probe the effects of specific genomic changes...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38619077/recommendations-for-the-management-of-initial-and-refractory-pediatric-status-dystonicus
#16
REVIEW
Lindsey M Vogt, Kathryn Yang, Gabriel Tse, Vicente Quiroz, Zainab Zaman, Laura Wang, Rasha Srouji, Amy Tam, Elicia Estrella, Shannon Manzi, Alfonso Fasano, Weston T Northam, Scellig Stone, Mahendranath Moharir, Hernan Gonorazky, Brian McAlvin, Monica Kleinman, Kerri L LaRovere, Carolina Gorodetsky, Darius Ebrahimi-Fakhari
Status dystonicus is the most severe form of dystonia with life-threatening complications if not treated promptly. We present consensus recommendations for the initial management of acutely worsening dystonia (including pre-status dystonicus and status dystonicus), as well as refractory status dystonicus in children. This guideline provides a stepwise approach to assessment, triage, interdisciplinary treatment, and monitoring of status dystonicus. The clinical pathways aim to: (1) facilitate timely recognition/triage of worsening dystonia, (2) standardize supportive and dystonia-directed therapies, (3) provide structure for interdisciplinary cooperation, (4) integrate advances in genomics and neuromodulation, (5) enable multicenter quality improvement and research, and (6) improve outcomes...
April 15, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38618439/a-narrative-review-on-managing-retinopathy-of-prematurity-insights-into-pathogenesis-screening-and-treatment-strategies
#17
REVIEW
Kratika Bishnoi, Roshan Prasad, Tanisha Upadhyay, Swapneel Mathurkar
Retinopathy of prematurity (ROP) is a rare proliferative ocular condition that can happen in premature babies (born preterm <36 weeks) or who weigh <1.5 kg at birth (low birth weight babies). ROP is a major cause of childhood blindness. It is a premature disease since retina vascularization is completed only by 40 weeks of life. The survivability for preterm infants has increased owing to recent improvements in neonatal care during the past decade. As a result, the prevalence of ROP has risen concurrently...
March 2024: Curēus
https://read.qxmd.com/read/38616217/issues-challenges-and-opportunities-for-economic-evaluations-of-orphan-drugs-in-rare-diseases-an-umbrella-review
#18
REVIEW
Tobias Sydendal Grand, Shijie Ren, James Hall, Daniel Oudin Åström, Stephane Regnier, Praveen Thokala
BACKGROUND AND OBJECTIVES: There are significant challenges when obtaining clinical and economic evidence for health technology assessments of rare diseases. Many of them have been highlighted in previous systematic reviews but they have not been summarised in a comprehensive manner. For all stakeholders working with rare diseases, it is important to be aware and understand these issues. The objective of this review is to identify the main challenges for the economic evaluation of orphan drugs in rare diseases...
April 14, 2024: PharmacoEconomics
https://read.qxmd.com/read/38614367/treating-alzheimer-s-disease-using-nanoparticle-mediated-drug-delivery-strategies-systems
#19
REVIEW
Aryan Kia Roghani, Ricardo Isaiah Garcia, Ali Roghani, Aananya Reddy, Sachi Khemka, Ruhananhad P Reddy, Vasanthkumar Pattoor, Michael Jacob, P Hemachandra Reddy, Ujala Sehar
The administration of promising medications for the treatment of neurodegenerative disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) is significantly hampered by the blood-brain barrier (BBB). Nanotechnology has recently come to light as a viable strategy for overcoming this obstacle and improving drug delivery to the brain. With a focus on current developments and prospects, this review article examines the use of nanoparticles to overcome the BBB constraints to improve drug therapy for AD The potential for several nanoparticle-based approaches, such as those utilizing lipid-based, polymeric, and inorganic nanoparticles, to enhance drug transport across the BBB are highlighted...
April 12, 2024: Ageing Research Reviews
https://read.qxmd.com/read/38610755/role-of-palliative-care-in-the-supportive-management-of-al-amyloidosis-a-review
#20
REVIEW
Muhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, Mathias Schlögl, Alexandra McDonald, Sandra Mazzoni, Jack Khouri, Louis Williams, Faiz Anwer, Shahzad Raza
Light chain amyloidosis is a plasma-cell disorder with a poor prognosis. It is a progressive condition, causing worsening pain, disability, and life-limiting complications involving multiple organ systems. The medical regimen can be complex, including chemotherapy or immunotherapy for the disease itself, as well as treatment for pain, gastrointestinal and cardiorespiratory symptoms, and various secondary symptoms. Patients and their families must have a realistic awareness of the illness and of the goals and limitations of treatments in making informed decisions about medical therapy, supportive management, and end-of-life planning...
March 29, 2024: Journal of Clinical Medicine
keyword
keyword
40913
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.